Market Overview:
The global hepatitis B diagnostic tests market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of hepatitis B, rising awareness about hepatitis B and its diagnosis, and technological advancements in diagnostic tests. The global hepatitis B diagnostic tests market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into enzyme immunoassay kits and point-of-care testing kits. Enzyme immunoassay kits are further subsegmented into qualitative assay kits and quantitative assay kits. Point-of-care testing Kits are further subsegmented into lateral flow assays (LFAs) and other point-of care assays (OPCAs). On the basis of application, the market is segmented into hospitals, clinics, diagnostic centres,, home care settings,. Hospitals account for a major share of this market owing to increased demand for accurate diagnosis and treatment options for patients with hepatitis B infection. Clinics are also expected to witness significant growth duringthe forecast period dueto rising demand for early diagnosisand treatment optionsfor various diseases includinghepatitisB infection .
Product Definition:
Hepatitis B Diagnostic Tests are used to diagnose hepatitis B. The tests can help doctors determine if a person has the virus, how much damage the virus has done to the liver, and whether treatment is needed.
Enzyme Immunoassay Kits:
Enzyme immunoassay (EIA) is a technique wherein the presence of an antibody in the blood sample reacts with antigen present in the test sample. The Enzyme-linked Immunosorbent Assay (ELISA) is one such example of an enzyme immunoassay. It was initially developed for detection and identification of microorganisms, including their toxins, coat antigens and vitamins.
Point-of-Care Testing Kits:
Point-of-care (POC) testing kits are used in the diagnosis of various diseases and health conditions at the time of its occurrence. POC tests are easy to use, provide rapid results, and reduce hospital stays. These factors make it more preferable for home healthcare settings such as nursing homes, hospitals outpatient departments etc.
Application Insights:
Based on application, the global hepatitis B diagnostic tests market is segmented into hospitals, clinics and diagnostics centers, home care settings, and others. Hospitals held the largest share in 2017 owing to high prevalence of HBV infection in patients with chronic liver diseases and rising awareness about early diagnosis. Furthermore, increasing investments by governments for construction of diagnostic centers may further propel growth over the forecast period.
Clinics & diagnostics centers are anticipated to witness lucrative growth over the forecast period due to increasing incidence of HBV infection among individuals without known source of exposure such as blood transfusion or injection drug use. Moreover, growing number of clinical trials for new generation antiviral drugs will boost product demand during future years.
The home care setting is expected to exhibit rapid growth owing to rising awareness about availability of affordable healthcare services among consumers globally along with technological advancements that facilitate easy handling.
Regional Analysis:
North America dominated the global hepatitis B diagnostic tests market in 2017. This can be attributed to the presence of a large number of players, high awareness levels coupled with relatively higher healthcare expenditure and better reimbursement policies. The U.S is one of the most affected countries globally by this disease as it has a very high population density along with an increasing prevalence rate. As per CDC, around 15 million people are living with chronic hepatitis B in U.S., which is projected to further escalate due to various factors such as drug abuse, unhealthy lifestyle etc.
Asia Pacific region is expected to grow at fastest pace during the forecast period owing to improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of hepatitis B infections
- Growing awareness about the benefits of early diagnosis and treatment of hepatitis B
- Rising demand for point-of-care diagnostic tests for rapid detection of hepatitis B infections
- Technological advancements in diagnostic testing methods for hepatitis B
- Growing number of public and private sector initiatives to promote screening and diagnosis of hepatitis B
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis B Diagnostic Tests Market Research Report
By Type
Enzyme Immunoassay Kits, Point-of-Care Testing Kits
By Application
Hospitals, Clinics, Diagnostic Centres, Home Care
By Companies
bioMerieux, Bio-Rad, DiaSorin, Abbott, Meridian Bioscience, Vista, Biogate, J.Mitra, Siemens Medical Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis B Diagnostic Tests Market Report Segments:
The global Hepatitis B Diagnostic Tests market is segmented on the basis of:
Types
Enzyme Immunoassay Kits, Point-of-Care Testing Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centres, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- bioMerieux
- Bio-Rad
- DiaSorin
- Abbott
- Meridian Bioscience
- Vista
- Biogate
- J.Mitra
- Siemens Medical Solutions
Highlights of The Hepatitis B Diagnostic Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enzyme Immunoassay Kits
- Point-of-Care Testing Kits
- By Application:
- Hospitals
- Clinics
- Diagnostic Centres
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis B Diagnostic Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are a few different diagnostic tests for hepatitis B. These tests can help doctors determine if someone has the virus and whether they need treatment. Some of the most common tests used to diagnose hepatitis B include: A blood test that measures how much virus is in a person's blood. This test is usually done when someone suspects they have the virus or when their doctor wants to check for signs of infection, such as fever, fatigue, and jaundice (a yellowing of the skin and eyes). An ultrasound exam that uses sound waves to see if there are any liver abnormalities in people with hepatitis B. This exam can be used to rule out other causes of jaundice, such as cirrhosis (a serious liver disease) or cancer. Ultrasound exams are not always necessary for diagnosis but may be helpful in some cases because they can show where on the liver damage has occurred.
Some of the key players operating in the hepatitis b diagnostic tests market are bioMerieux, Bio-Rad, DiaSorin, Abbott, Meridian Bioscience, Vista, Biogate, J.Mitra, Siemens Medical Solutions.
The hepatitis b diagnostic tests market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis B Diagnostic Tests Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis B Diagnostic Tests Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis B Diagnostic Tests Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis B Diagnostic Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis B Diagnostic Tests Market Size & Forecast, 2020-2028
4.5.1 Hepatitis B Diagnostic Tests Market Size and Y-o-Y Growth
4.5.2 Hepatitis B Diagnostic Tests Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Enzyme Immunoassay Kits
5.2.2 Point-of-Care Testing Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centres
6.2.4 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis B Diagnostic Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis B Diagnostic Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Enzyme Immunoassay Kits
9.6.2 Point-of-Care Testing Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centres
9.10.4 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Enzyme Immunoassay Kits
10.6.2 Point-of-Care Testing Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centres
10.10.4 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Enzyme Immunoassay Kits
11.6.2 Point-of-Care Testing Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centres
11.10.4 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Enzyme Immunoassay Kits
12.6.2 Point-of-Care Testing Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centres
12.10.4 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Enzyme Immunoassay Kits
13.6.2 Point-of-Care Testing Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centres
13.10.4 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis B Diagnostic Tests Market: Competitive Dashboard
14.2 Global Hepatitis B Diagnostic Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 bioMerieux
14.3.2 Bio-Rad
14.3.3 DiaSorin
14.3.4 Abbott
14.3.5 Meridian Bioscience
14.3.6 Vista
14.3.7 Biogate
14.3.8 J.Mitra
14.3.9 Siemens Medical Solutions
